Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

Completed

Conditions studied: Melanoma, Herpetic Infection

In brief

A postmarketing Cohort study of Melanoma patients treated with IMLYGIC (Talimogene Laherparepvec) in clinical Practice to Characterize the risk of herpetic infection with detection of Talimogene Laherparepvec DNA among patients, close contacts, and health care providers; and long term safety in treated patients for up to 5 years after the first IMLYGIC dose.

Key facts

Study ID

NCT02910557

Run by

Amgen

People needed

187

Starts

2017-08-10

Expected to finish

2026-01-30

Last updated by the study team

2026-02-05

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has provided written informed consent
• Patient is an adult (≥ 18 years of age at the time of informed consent) with a diagnosis of melanoma
• Patient enrolled within 1 month of receiving the first dose of IMLYGIC for the treatment of melanoma

You may not qualify if…

• Patient has a prior history of being a subject in an interventional clinical trial for IMLYGIC

Where it is running

• Corazon United States of America, LLC doing business as Life Clinical Trials — Coral Springs, Florida, United States
• Mercy Medical Center — Baltimore, Maryland, United States
• Jefferson City Medical Group PC — Jefferson City, Missouri, United States
• TriHealth Cancer Institute - Kenwood — Cincinnati, Ohio, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
• Allegheny Health Network — Pittsburgh, Pennsylvania, United States
• University of Tennessee Medical Center — Knoxville, Tennessee, United States
• Intermountain Medical Center — Murray, Utah, United States
• University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States
• Medizinische Universitaet Graz — Graz, Austria
• Ordensklinikum Linz Elisabethinen — Linz, Austria
• Landeskrankenhaus Salzburg — Salzburg, Austria
• Universitaetsklinikum Sankt Poelten — Sankt Pölten, Austria
• Rambam Medical Center — Haifa, Israel
• Sheba Medical Center — Ramat Gan, Israel
• Universitaetsspital Basel — Basel, Switzerland
• Kantonsspital Graubuenden — Chur, Switzerland
• Universitaetsspital Zuerich — Zuerich Flughafen, Switzerland
• Cheltenham General Hospital — Cheltenham, United Kingdom
• Guys Hospital — London, United Kingdom
• Royal Marsden Hospital — London, United Kingdom
• Churchill Hospital — Oxford, United Kingdom
• Musgrove Park Hospital — Taunton, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.